Bonesupport Holding AB logo

BONEX - Bonesupport Holding AB Share Price

SEK35.5 0.5  1.4%

Last Trade - 5:00pm

Sector
Healthcare
Size
Small Cap
Market Cap £144.5m
Enterprise Value £135.1m
Revenue £10.5m
Position in Universe 690th / 1714
Bullish
Bearish
Unlock BONEX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BONEX Revenue Unlock BONEX Revenue

Net Income

BONEX Net Income Unlock BONEX Revenue

Normalised EPS

BONEX Normalised EPS Unlock BONEX Revenue

PE Ratio Range

BONEX PE Ratio Range Unlock BONEX Revenue

Dividend Yield Range

BONEX Dividend Yield Range Unlock BONEX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BONEX EPS Forecasts Unlock BONEX Revenue
Profile Summary

Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Public Since June 21, 2017
No. of Shareholders: n/a
No. of Employees: 80
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 51,948,217
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BONEX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BONEX
Upcoming Events for BONEX
Wednesday 26th February, 2020
Full Year 2019 Bonesupport Holding AB Earnings Call
Similar to BONEX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.